Dr. Sandoval Sus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
603 N Flamingo Rd
Ste 151
Pembroke Pines, FL 33028Phone+1 954-265-4325Fax+1 954-443-4615
Education & Training
University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2014 - 2017
Certifications & Licensure
FL State Medical License 2013 - 2025
MA State Medical License 2011 - 2011- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsEfficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy.Madiha Iqbal, Deepa Jagadeesh, Julio Chavez, Arushi Khurana, Allison Rosenthal
Bone Marrow Transplantation. 2024-02-01 - 10 citationsAnti-CD19 chimeric antigen receptor T-cell therapy in B-cell lymphomas: current status and future directions.Julio C. Chavez, Farah Yassine, Jose Sandoval-Sus, Mohamed A. Kharfan-Dabaja
International Journal of Hematologic Oncology. 2021-06-01 - 18 citationsAn international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma.Juan Pablo Alderuccio, Luca Arcaini, Marcus P Watkins, Anne W Beaven, Anne W Beaven
Blood Advances. 2022-04-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
